Increased expression of apoptotic markers in melanoma

Melanoma Research

Volumn 13, Issue 2, 2003, Pages 137-145

  Slater, Michael ^a   Scolyer, Richard A ^b   Gidley Baird, Angus ^a   Thompson, John F ^b   Barden, Julian A ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Apoptosis; Malignancy; Melanoma; Purinergic receptors

Indexed keywords

CASPASE 3; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; TELOMERASE; UVOMORULIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; KERATINOCYTE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM;

APOPTOSIS; CADHERINS; CASPASE 3; CASPASES; CELL ADHESION; CELL DIVISION; CELL NUCLEUS; DERMIS; ENZYME PRECURSORS; EPIDERMIS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MELANOCYTES; MELANOMA; RECEPTORS, PURINERGIC P2; TELOMERASE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0038242013     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200304000-00005     Document Type: Article

References (36)

1. Lang PG Jr. Malignant melanoma. Med Clin North Am 1998; 82(6):1325-1358.
2. Yang P, Becker D. Telomerase activity and expression of apoptosis and anti-apoptosis regulators in the progression pathway of human melanoma. Int J Oncol 2000; 17(5):913-919.
3. Kaiser HE, Bodey B Jr, Siegel SE, Groger AM, Bodey B. Spontaneous neoplastic regression: the significance of apoptosis. In Vivo 2000; 14(6):773-788.
4. Slater M, Delprado WJ, Murphy CR, Barden JA. Detection of preneoplasia in histologically normal prostate biopsies. Prostate Cancer Prostatic Dis 2001; 4:92-96.
5. 5 receptors in adults with overactive detrusor contractility and urge incontinence. J Neurosci 2001; 21:U17-U22.
6. Ray F, Huang W, Slater M, Barden J. Purinergic receptor distribution in endothelial cells in blood vessels: a basis for selecting coronary artery grafts. Atherosclerosis 2002; 162:55-61.
7. Dutton J, Hansen M, Barden J, Bennett M. Development of the distribution of single P2X homomeric and heteromeric receptor clusters on smooth muscle cells in relation to nerve varicosities in the rat urinary bladder. J Neurocytol 1999; 28:3-15.
8. Barden J, Cottee L, Bennett M. Vesicle-associated proteins and P2X receptor clusters at single sympathetic varicosities in mouse vas deferens. J Neurocytol 1999; 28:469-480.
9. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass M, et al. A mammalian telomerase-associated protein. Science 1997; 275:973-977.
10. Barden JA, Cuthbertson RM, Jia-Zhen W, Moseley JM, Kemp BE. Solution structure of PTHrP(Ala15)(1-34). J Biol Chem 1997; 272:29572-29578.
11. Williams IR, Kupper TS. Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci 1996; 58(18):1485-1507.
12. Li G, Herlyn M. Dynamics of intercellular communication during melanoma development. Mol Med Today 2000; 6(4):163-169.
13. Li G, Satyamoorthy K, Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 2001; 61(9):381g-3825.
14. Voura EB, Sandig M, Siu CH. Cell-cell interactions during transendothelial migration of tumor cells. Microsc Res Tech 1998; 43(3):265-275.
15. Gong Y, Blok U, Perry JE, Lindzey JK, Tindall DJ. Calcium regulation of androgen receptor expression in the human prostate cancer cell line LNCaP. Endocrinology 1995; 136(5):2172-2178.
16. 2+-binding protein family. Biometals 1998; 11(4):383-397.
17. Keirsebilck A, Bonne S, Bruyneel E, Vermassen P, Lukanidin E, Mareel M, et al. E-cadherin and metastasin (Mts-1/S100a4) expression levels are inversely regulated in two tumor cell families. Cancer Res 1998; 58(20):4587-4591.
18. 2+ in human neutrophils: initiation by adherence receptors of the integrin family. J Cell Biol 1991; 112(6):1249-1257.
19. Schwartz M, Ingber D, Lawrence M, Springer T, Lechene C. Multiple integrins share the ability to induce elevation of intracellular pH. Exp Cell Res 1991; 195:533-535.
20. Cybulsky AV, Carbonetto S, Cyr MD, McTavish AJ, Huang Q. Extracellular matrix-stimulated phospholipase activation is mediated by beta 1-integrin. Am J Physiol 1993; 264(2 pt 1):C323-332.
21. Kornberg L, Juliano R. Signal transduction from the extracellular matrix: the integrin-tyrosine kinase connection. Trends Pharmacol Sci 1992; 13:93-95.
22. Figueroa JP, Massmann GA. Estrogen increases nitric oxide synthase activity in the uterus of nonpregnant sheep. Am J Obstet Gynecol 1995; 173(5):1539-1545.
23. Pouli AE, Emmanouilidou E, Zhao C, Wasmeier C, Hutton JC, Rutter GA. Secretory-granule dynamics visualized in vivo with a phogrin green fluorescent protein chimaera. Biochem J 1998; 333(pt 1):193-199.
24. Chvatchko Y, Valera S, Aubry JP, Renno T, Buell G, Bonnefoy JY. The involvement of an ATP-gated ion channel, P2X1, in thymocyte apoptosis. Immunity 1996; 5(3):275-283.
25. 2+ channel modulation in bovine chromaffin cells. Neuron 1998; 20(6):1255-1268.
26. Valera S, Talabot F, Evans RJ, Gos A, Antonarakis SE, Morris MA, et al. Characterization and chromosomal localization of a human P2X receptor from the urinary bladder. Receptors Channels 1995; 3(4):283-289.
27. 2+ by the intracellular non-mitochondrial calcium store in uterine smooth muscle cells. Ukr Biokhim Zh 1997; 69(2):19-29.
28. Valera S, Hussy N, Evans RJ, Adami N, North RA, Surprenant A, et al. A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature 1994; 371(6497):516-589.
29. Hattori T, Hayashi H, Chiba T, Onozaki K. Activation of two distinct anti-proliferative pathways, apoptosis and p38 MAP kinase-dependent cell cycle arrest, by tumor necrosis factor in human melanoma cell line A375. Eur Cytokine Netw 2001; 12(2):244-252.
30. Salvucci O, Carsana M, Bersani I, Tragni G, Anichini A. Antiapoptotic role of endogenous nitric oxide in human melanoma cells. Cancer Res 2001; 61(1):318-326.
31. Batra S, Al-Hijji J. Characterization of nitric oxide synthase activity in rabbit uterus and vagina: downregulation by estrogen. Life Sci 1998; 62(23):2093-2100.
32. Orlando C, Gelmini S, Selli C, Pazzagli M. Telomerase in urological malignancy. J Urol 2001; 166(2):666-673.
33. Miracco C, Pacenti L, Santopietro R, Biagioli M, Fimiani M, Perotti R, et al. Detection of telomerase activity and correlation with mitotic and apoptotic indices, Ki-67 and expression of cyclins D1 and A in cutaneous melanoma. Int J Cancer 2000; 88(3):411-416.
34. Ramirez RD, D'Atri S, Pagani E, Faraggiana T, Lacal PM, Taylor RS, et al. Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma. Neoplasia 1999; 1(1):42-49.
35. Villa R, Porta CD, Folini M, Daidone MG, Zaffaroni N. Possible regulation of telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma. J Invest Dermatol 2001; 116(6):867-873.
36. Ren JG, Xia HL, Tian YM, Just T, Cai GP, Dai YR. Expression of telomerase inhibits hydroxyl radical-induced apoptosis in normal telomerase negative human lung fibroblasts. FEBS Lett 2001; 488(3):133-138.